Zurich Cantonal Bank
TVRD

Zurich Cantonal Bank’s Tvardi Therapeutics TVRD Stock Holding History

Zurich Cantonal Bank’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-211
Closed -$37.4K – 2865
2023
Q1 		$37.4K Hold
211
– – ﹤0.01% 2658
2022
Q4 		$81.7K Buy
211
+47
+29% +$17.9K ﹤0.01% 2391
2022
Q3 		$55K Hold
164
– – ﹤0.01% 2563
2022
Q2 		$54K Hold
164
– – ﹤0.01% 2560
2022
Q1 		$72K Sell
164
-120
-42% -$49.3K ﹤0.01% 2420
2021
Q4 		$124K Sell
284
-12
-4% -$6.03K ﹤0.01% 2395
2021
Q3 		$164K Buy
296
+4
+1% +$2.01K ﹤0.01% 2047
2021
Q2 		$150K Buy
292
+128
+78% +$81.1K ﹤0.01% 2009
2021
Q1 		$128K Hold
164
– – ﹤0.01% 2025
2020
Q4 		$89K Hold
164
– – ﹤0.01% 2264
2020
Q3 		$75K Hold
164
– – ﹤0.01% 2110
2020
Q2 		$101K Buy
164
+96
+141% +$53K ﹤0.01% 1937
2020
Q1 		$32K Hold
68
– – ﹤0.01% 2156
2019
Q4 		$40K Hold
68
– – ﹤0.01% 2260
2019
Q3 		$45K Hold
68
– – ﹤0.01% 2114
2019
Q2 		$53K Hold
68
– – ﹤0.01% 2028
2019
Q1 		$48K Sell
68
-32
-32% -$19.2K ﹤0.01% 2037
2018
Q4 		$47K Buy
100
+27
+37% +$17.4K ﹤0.01% 2074
2018
Q3 		$63K Hold
73
– – ﹤0.01% 2010
2018
Q2 		$50K Sell
73
-47
-39% -$23.9K ﹤0.01% 2133
2018
Q1 		$53K Hold
120
– – ﹤0.01% 2035
2017
Q4 		$53K Buy
+120
New +$54.7K ﹤0.01% 2032

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zurich Cantonal Bank's TVRD Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 211 shares — an estimated $37.4K sold.

Zurich Cantonal Bank first reported a position in TVRD in Q4 2017 and held it in 22 quarters. The position peaked at $164K in Q3 2021. 136 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

  • Zurich Cantonal Bank reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 211 Tvardi Therapeutics shares in Q2 2023, an estimated $37.4K.
  • Zurich Cantonal Bank first reported a position in Tvardi Therapeutics in Q4 2017 and held it in 22 quarters.
  • Zurich Cantonal Bank's Tvardi Therapeutics position peaked at $164K in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.